Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2014

Dec 16, 2014

34129_dirs_2014-12-16_99832f3c-6b09-407e-8ff9-60c37d029c45.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2014-12-12

Reporting Person: Risser Eric Blasius (VP, Business Development)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-12 Employee Stock Option (right to buy) $29.68 A 50000 Acquired 2024-12-12 Common Stock (50000) Direct

Footnotes

F1: 12.5% of the option becomes exercisable on June 12, 2015 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter.